Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study.
Cinzia TesauroAnne Katrine SimonsenMarie Bech AndersenKamilla Wandsoe PetersenEmil Laust KristoffersenLine AlgreenNoriko Yokoyama HansenAnne Bech AndersenAnn Katrine JakobsenMagnus StougaardPavel GromovBirgitta R KnudsenIrina GromovaPublished in: BMC cancer (2019)
TOP1 activity is not a marker for CPT sensitivity in breast cancer.